Profile
Steven M.
Toler served as Vice President-Pharmaceutical Development at Bellicum Pharmaceuticals, Inc. from 2015 to 2018 and as Vice President-Clinical Pharmaceutical Sciences at Targacept, Inc. from 2013 to 2015.
He holds a doctorate degree from Mercer University and Chandler Medical Center, and an undergraduate degree from Georgia State University.
Former positions of Steven M. Toler
| Companies | Position | End |
|---|---|---|
| BELLICUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/05/2018 |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Corporate Officer/Principal | 31/03/2015 |
Training of Steven M. Toler
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel cellular immunotherapies for various forms of cancer | Health Technology |
Mercer University
Mercer University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Targacept, Inc.
Targacept, Inc. Pharmaceuticals: OtherHealth Technology Discovers and develops nicotinic acetylcholine receptor based therapies | Health Technology |
Georgia State University
Georgia State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chandler Medical Center
Chandler Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Steven M. Toler
















